Deficiencies [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2018-02-01 16:48 (1882 d 16:19 ago) – Posting: # 18323
Views: 19,826

Dear Detlew,

❝ Also you may be correct I must confess that I seldom or never had done this alpha-adjustment in case I used a higher order design. Reasons:

Never had problems with using un-adjusted alpha :cool: in more then 30 years.


I faced two.
  1. In a dose-linearity study (two adjusted doses compared to one – i.e., not proportionality by the power model). Very similar to the example by Hauschke et al. in chapter 7.4.1 where we find:

    “… for a joint decision rule where all requirements must be fulfilled, no adjustment of the comparisonwise type I error is needed to keep the familywise type I error under control.”

    Received a deficiency letter from the BfArM in 2005 asking for adjustment:

    “Aufgrund der multiplen Berechnung (2 Testpräparate) sollte das Bonferroni-adjustierte 95% Konfidenzintervall […] des Referenzproduktes angenommen werden.”

  2. One of my clients aimed at showing BE of two products (tablet, capsule) vs. the reference. One passed and the other one failed. Only the passing one was submitted. Received a deficiency this year from an undisclosed agency:

    “Please provide a statistical analysis with proper alpha-adjustment […] as we are of the opinion, that alpha-adjustment is required for this design.”


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,557 posts in 4,724 threads, 1,608 registered users;
21 visitors (0 registered, 21 guests [including 9 identified bots]).
Forum time: 10:08 CEST (Europe/Vienna)

A scientist’s aim in a discussion with his colleagues
is not to persuade, but to clarify.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5